Ju S - Search Results

1

Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β.

Tang H, Liao Y, Chen G, Xu L, Zhang C, Ju S, Zhou S. Tang H, et al. Among authors: ju s. Med Oncol. 2012 Dec;29(4):2640-8. doi: 10.1007/s12032-012-0198-8. Epub 2012 Mar 17. Med Oncol. 2012. PMID: 22427208

2

[Gender-associated differences of lung cancer and mechanism].

Xing X, Liao Y, Tang H, Chen G, Ju S, You L. Xing X, et al. Among authors: ju s. Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):625-30. doi: 10.3779/j.issn.1009-3419.2011.07.12. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21762635 Free PMC article. Review. Chinese.

3

Effects of insulin-like growth factor 1 receptor and its inhibitor AG1024 on the progress of lung cancer.

Wei YH, Tang HX, Liao YD, Fu SL, Xu LQ, Chen G, Zhang C, Ju S, Liu ZG, You LK, Yu L, Zhou S. Wei YH, et al. Among authors: ju s. J Huazhong Univ Sci Technolog Med Sci. 2015 Dec;35(6):834-841. doi: 10.1007/s11596-015-1515-1. Epub 2015 Dec 16. J Huazhong Univ Sci Technolog Med Sci. 2015. PMID: 26670433

4

microRNA-664 enhances proliferation, migration and invasion of lung cancer cells.

Zhu X, Ju S, Yuan F, Chen G, Shu Y, Li C, Xu Y, Luo J, Xia L. Zhu X, et al. Among authors: ju s. Exp Ther Med. 2017 Jun;13(6):3555-3562. doi: 10.3892/etm.2017.4433. Epub 2017 May 5. Exp Ther Med. 2017. PMID: 28588679 Free PMC article.

5

The effect and mechanism of miR-210 in down-regulating the autophagy of lung cancer cells.

Ju S, Liang Z, Li C, Ding C, Xu C, Song X, Zhao J. Ju S, et al. Pathol Res Pract. 2019 Mar;215(3):453-458. doi: 10.1016/j.prp.2018.12.018. Epub 2018 Dec 12. Pathol Res Pract. 2019. PMID: 30573163

6

CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1.

Wang Q, Xie Z, Li C, Xu C, Ding C, Ju S, Chen J, Cui Z, Chen C, Gu B, Wei T, Zhao J. Wang Q, et al. Among authors: ju s. J Mol Histol. 2022 Aug;53(4):657-667. doi: 10.1007/s10735-022-10075-9. Epub 2022 Jun 18. J Mol Histol. 2022. PMID: 35716330

7

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.

Zeng W, Wang J, Yang J, Chen Z, Cui Y, Li Q, Luo G, Ding H, Ju S, Li B, Chen J, Xie Y, Tong X, Liu M, Zhao J. Zeng W, et al. Among authors: ju s. Front Immunol. 2023 Jul 7;14:1217590. doi: 10.3389/fimmu.2023.1217590. eCollection 2023. Front Immunol. 2023. PMID: 37492563 Free PMC article.

8

Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma.

Yang J, Luo G, Li C, Zhao Z, Ju S, Li Q, Chen Z, Ding C, Tong X, Zhao J. Yang J, et al. Among authors: ju s. BMC Cancer. 2022 May 30;22(1):589. doi: 10.1186/s12885-022-09685-z. BMC Cancer. 2022. PMID: 35637432 Free PMC article.

9

Efficient Predictor for Immunotherapy Efficacy: Detecting Pan-Clones Effector Tumor Antigen-Specific T Cells in Blood by Nanoparticles Loading Whole Tumor Antigens.

Zeng W, Wang J, Chen Z, Yang J, Zhu A, Zheng Y, Chen X, Liu Y, Wu L, Xie Y, Ju S, Chen J, Ding C, Li C, Tong X, Liu M, Zhao J. Zeng W, et al. Among authors: ju s. Adv Sci (Weinh). 2025 Jan;12(2):e2409913. doi: 10.1002/advs.202409913. Epub 2024 Nov 5. Adv Sci (Weinh). 2025. PMID: 39498880 Free PMC article.

10

Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.

Ju S, Cui Z, Hong Y, Wang X, Mu W, Xie Z, Zeng X, Su L, Lin X, Zhang Z, Zhang Q, Song X, You S, Chen R, Chen W, Xu C, Zhao J. Ju S, et al. Cancer. 2023 Aug 1;129(15):2422-2430. doi: 10.1002/cncr.34804. Epub 2023 Apr 25. Cancer. 2023. PMID: 37096747 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,785 results

Search Page

Filters